The scoping review examines how artificial intelligence (AI) is applied across all stages of medication management in rural healthcare settings, from prescribing to post-administration monitoring. It identifies four main themes: the types of AI used, the medication phases impacted, the effectiveness in reducing errors, and rural-specific challenges such as infrastructure and alert fatigue. Studies show machine‑learning surveillance can cut prescribing and transcription errors by 34% to 80%, yet barriers like governance gaps, funding limits, and clinician resistance remain.
arXiv:2606. 28692v1 Announce Type: new Abstract: Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy.
arXiv:2607. 12527v1 Announce Type: new Abstract: Musculoskeletal diseases are among the leading causes of disability worldwide and create the greatest global need for rehabilitation.
arXiv:2512. 01241v4 Announce Type: replace-cross Abstract: Large language models (LLMs) and medical AI tools are routinely used by physicians and patients for medical advice, yet their clinical safety profiles remain poorly characterized.
arXiv:2512. 01241v3 Announce Type: replace-cross Abstract: Large language models (LLMs) are routinely used by physicians and patients for medical advice, yet their clinical safety profiles remain poorly characterized.
arXiv:2607. 15394v1 Announce Type: new Abstract: Black-box models limit the adoption of artificial intelligence in medicine due to their lack of interpretability and reproducibility.
arXiv:2607. 08038v1 Announce Type: new Abstract: Diagnostic error is a major threat to patient safety, yet current large language model (LLM) systems often treat diagnosis as a one-shot prediction task, lacking safeguards against missed high-risk alternatives or rigorous verification of their reasoning.
arXiv:2607. 20542v1 Announce Type: cross Abstract: A critical challenge in healthcare systems in low- and middle-income countries (LMICs) is the efficient and equitable allocation of scarce resources, particularly essential medicines.
arXiv:2407. 11823v4 Announce Type: replace Abstract: The United States Food and Drug Administration's (FDA's) 510(k) pathway allows manufacturers to gain medical device approval by demonstrating substantial equivalence to a legally marketed device.
arXiv:2606. 26205v1 Announce Type: new Abstract: Patients increasingly seek medication information online, yet safety knowledge for psychiatric drugs is split between regulatory adverse-event records, which are authoritative but abstract, and patient narratives, which are experience-near but unvalidated.
arXiv:2607. 24814v1 Announce Type: new Abstract: Access to specialist clinical expertise remains severely limited across sub-Saharan Africa, where physician-to-patient ratios can fall below 1:25,000 in rural settings.
arXiv:2608. 12360v1 Announce Type: cross Abstract: Background: AI/ML-enabled medical devices are increasingly deployed in healthcare under evolving regulatory frameworks.
arXiv:2608. 06112v1 Announce Type: new Abstract: Hospitals are rapidly adopting artificial intelligence for triage, imaging, scheduling etc.